New consent process for use of newborn screening blood samples
Part of Genetic & congenital clinical trials.
This trial tests a new, easier-to-understand consent process for mothers who just gave birth. If you join, you will be asked for permission to use a small leftover blood sample from your baby's newborn screening for research purposes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You speak English, Spanish, or Arabic.
- You have just given birth and are currently in the Mother & Baby Unit at the hospital.
- Your baby was born full-term (at least 37 weeks of pregnancy).
- Your baby is not in the Neonatal Intensive Care Unit (NICU).
- You are not planning to place your baby for adoption, and legal guardianship is known.
- You are willing to take part in a new way of asking for permission to use leftover newborn screening blood samples for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps pregnant people make informed choices about genetic screening tests by providing clear, timely information. Researchers want to learn the best way to explain screening options so you can decide what's right for you and your family.
This pilot study tries a systematic way to look for several rare “lysosomal storage” diseases in newborns using a specialized lab test on routine blood samples. It may help detect these conditions earlier so treatment can start sooner if needed.
This study tests if a digital media tool helps parents decide to join the WHEAT Trial, which studies a treatment for very premature babies. If you are considering the WHEAT Trial for your baby, this study may apply to you.
This study tests a new blood test during early pregnancy that can screen for certain genetic conditions by analyzing fetal cells. A simple blood draw may help detect potential chromosomal abnormalities earlier and more safely than traditional methods.
This trial tests whether watching a digital story can help expecting mothers learn more about newborn screening and feel more positive about it. You may join if you are 28-32 weeks pregnant, speak Turkish, and have a smartphone with internet.
This study tests a new way to screen newborns for rare genetic diseases using a blood sample. It aims to find treatable conditions early so that babies can get care sooner.
Hear when a new Implementation Science trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.